Ratings DR Horton BOERSE MUENCHEN

Equities

HO2

US23331A1097

Market Closed - BOERSE MUENCHEN 20:43:09 14/06/2024 BST 5-day change 1st Jan Change
132.9 EUR -0.49% Intraday chart for DR Horton +1.68% -2.84%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company's attractive earnings multiples are brought to light by a P/E ratio at 10.04 for the current year.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

Ratings chart - Surperformance

Sector: Homebuilding

1st Jan change Capi. Investor Rating ESG Refinitiv
-2.84% 47.02B -
+10.53% 24B
C-
-4.21% 16.64B
B+
+11.91% 14.44B
B+
+16.08% 12.25B
C+
+32.88% 7.26B
A-
+7.30% 6.75B
B
+0.85% 6.66B
B+
-13.10% 6.01B
C+
+10.58% 5.96B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW